PAHC
Phibro Animal Health Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$38.24
−0.88%Aug 26, 2026, 20:20 UTC
Phibro Animal Health Corporation reported financial results for the fourth quarter and fiscal year ended June 30, 2026, with net sales of $396.7 million and net income of $21.7 million for the quarter, and provided financial guidance for fiscal year 2027.
Jul 28, 2026, 20:10 UTC
Phibro Animal Health Corporation's board declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on September 23, 2026, to stockholders of record on September 2, 2026.